Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00716209|
Recruitment Status : Unknown
Verified March 2014 by Haematology-Oncology, National University Hospital, Singapore.
Recruitment status was: Active, not recruiting
First Posted : July 16, 2008
Last Update Posted : March 5, 2014
The proposal seeks to establish:
- A comprehensive compilation (database) of clinical information comprising clinical, histopathological, treatment and follow-up characteristics of past and future gastrointestinal cancer (GIC) cases in Singapore that can be shared by investigators. The characteristics will include clinical (eg age, sex, stage), histopathological (eg. grade, type), treatment (eg. treatment status, regimens) and outcome data (eg. survival, toxicity) from medical records.
- A collection (bank) of corresponding frozen and fixed tissue, blood and processed samples (enriched blood mononuclear cells, protein, RNA, DNA, tissue arrays) in Singapore that can be shared by the investigators.
- A gastrointestinal cancer co-operative group (GCCG) of clinicians and scientists researching prognostic and predictive markers in GIC, which will benefit from the multi-disciplinary knowledge, information and samples of its members.
- To characterise genetic polymorphisms related to Gastrointestinal cancer chemotherapy treatment in controls (healthy volunteers)
|Condition or disease|
|Study Type :||Observational|
|Official Title:||Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers|
|Study Start Date :||September 2012|
|Estimated Primary Completion Date :||December 2014|
Patients with cancers of the gastrointestinal tract (eg. colorectal, gastric, pancreatic, esophageal)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00716209
|National University Hospital|
|Principal Investigator:||Ross Andrew Soo, MBBS||National University Hospital, Singapore|
|Principal Investigator:||Alex Chang||Johns Hopkins Singapore International Medical Centre|
|Principal Investigator:||Chung Yip Chan||Tan Tock Seng Hospital|